Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point.

Abstract

There are multiple challenges toward the identification and acceptance of a meaningful reduction-based endpoint for use in drug use disorder medication efficacy clinical trials. Evaluation of change in diagnostic criteria, and severity metrics based on criterion counts, may be a promising approach for future research.